April 6 (Reuters) - Replicel Life Sciences Inc RP.V
* Replicel life sciences announces restructuring, cost
reductions and closing of private placement
* Board of directors has authorized a plan to downsize all
non-critical programs and staff
* Closed non-brokered private placement of 1.9 million
shares at a price of $0.20 per share
Source text for Eikon: ID:nCCN4txgd7
Further company coverage: RP.V